Metralindole

This classification denotes an antidepressant agent with the molecular formula C15H17N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2QW3FL6OPA, chemically known as 2,4,5,6-tetrahydro-9-methoxy-4-methyl-1h-3,4,6a-triazafluoranthene but generally known as metralindole, which bears US NIH Compound Identifier 68713. European Medicines Agency schedules Metralindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08915MIG. The term METRALINDOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). METRALINDOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metralindole under HS 29335995 and SITC 51576. As of Q4 2014, METRALINDOLE remains the US FDA Preferred Term for this commodity. Metralindole bears US NLM identifiers UMLS ID C0066473 and NCI Concept Code C66137. SMILES: O(c1cc2c3c4n(CCN(C4=NCC3)C)c2cc1)C.